Polycystic Ovary Syndrome Treatment Market, Global Outlook and Forecast 2023-2028

Report ID: 1568673 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Polycystic Ovary Syndrome Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Polycystic Ovary Syndrome Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Polycystic Ovary Syndrome Treatment Overall Market Size
    2.1 Global Polycystic Ovary Syndrome Treatment Market Size: 2021 VS 2028
    2.2 Global Polycystic Ovary Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Polycystic Ovary Syndrome Treatment Players in Global Market
    3.2 Top Global Polycystic Ovary Syndrome Treatment Companies Ranked by Revenue
    3.3 Global Polycystic Ovary Syndrome Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Polycystic Ovary Syndrome Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Polycystic Ovary Syndrome Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Polycystic Ovary Syndrome Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Polycystic Ovary Syndrome Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Polycystic Ovary Syndrome Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Polycystic Ovary Syndrome Treatment Market Size Markets, 2021 & 2028
        4.1.2 Oral Contraceptives
        4.1.3 Insulin Sensitizing Agents
        4.1.4 Anti-Depressants
        4.1.5 Ornithine Decarboxylase Inhibitors
        4.1.6 Aromatase Inhibitors
        4.1.7 Diuretics
    4.2 By Type - Global Polycystic Ovary Syndrome Treatment Revenue & Forecasts
        4.2.1 By Type - Global Polycystic Ovary Syndrome Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Polycystic Ovary Syndrome Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Polycystic Ovary Syndrome Treatment Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Drug Stores
    5.2 By Application - Global Polycystic Ovary Syndrome Treatment Revenue & Forecasts
        5.2.1 By Application - Global Polycystic Ovary Syndrome Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Polycystic Ovary Syndrome Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Polycystic Ovary Syndrome Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Polycystic Ovary Syndrome Treatment Revenue & Forecasts
        6.2.1 By Region - Global Polycystic Ovary Syndrome Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Polycystic Ovary Syndrome Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Polycystic Ovary Syndrome Treatment Revenue, 2017-2028
        6.3.2 US Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.3.3 Canada Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.3.4 Mexico Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Polycystic Ovary Syndrome Treatment Revenue, 2017-2028
        6.4.2 Germany Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.3 France Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.4 U.K. Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.5 Italy Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.6 Russia Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.4.8 Benelux Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Polycystic Ovary Syndrome Treatment Revenue, 2017-2028
        6.5.2 China Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.5.3 Japan Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.5.4 South Korea Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.5.6 India Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Polycystic Ovary Syndrome Treatment Revenue, 2017-2028
        6.6.2 Brazil Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.6.3 Argentina Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Polycystic Ovary Syndrome Treatment Revenue, 2017-2028
        6.7.2 Turkey Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.7.3 Israel Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
        6.7.5 UAE Polycystic Ovary Syndrome Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.1.4 Sanofi Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Novartis AG
        7.2.1 Novartis AG Corporate Summary
        7.2.2 Novartis AG Business Overview
        7.2.3 Novartis AG Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.2.4 Novartis AG Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.2.5 Novartis AG Key News
    7.3 Teva Pharmaceutical Industries Limited 
        7.3.1 Teva Pharmaceutical Industries Limited  Corporate Summary
        7.3.2 Teva Pharmaceutical Industries Limited  Business Overview
        7.3.3 Teva Pharmaceutical Industries Limited  Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.3.4 Teva Pharmaceutical Industries Limited  Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.3.5 Teva Pharmaceutical Industries Limited  Key News
    7.4 Addex Therapeutics Ltd. 
        7.4.1 Addex Therapeutics Ltd.  Corporate Summary
        7.4.2 Addex Therapeutics Ltd.  Business Overview
        7.4.3 Addex Therapeutics Ltd.  Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.4.4 Addex Therapeutics Ltd.  Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.4.5 Addex Therapeutics Ltd.  Key News
    7.5 BIOCAD
        7.5.1 BIOCAD Corporate Summary
        7.5.2 BIOCAD Business Overview
        7.5.3 BIOCAD Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.5.4 BIOCAD Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.5.5 BIOCAD Key News
    7.6 Merck KGaA
        7.6.1 Merck KGaA Corporate Summary
        7.6.2 Merck KGaA Business Overview
        7.6.3 Merck KGaA Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.6.4 Merck KGaA Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.6.5 Merck KGaA Key News
    7.7 AstraZeneca plc.
        7.7.1 AstraZeneca plc. Corporate Summary
        7.7.2 AstraZeneca plc. Business Overview
        7.7.3 AstraZeneca plc. Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.7.4 AstraZeneca plc. Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.7.5 AstraZeneca plc. Key News
    7.8 Bristol Myers Squibb Co. 
        7.8.1 Bristol Myers Squibb Co.  Corporate Summary
        7.8.2 Bristol Myers Squibb Co.  Business Overview
        7.8.3 Bristol Myers Squibb Co.  Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.8.4 Bristol Myers Squibb Co.  Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.8.5 Bristol Myers Squibb Co.  Key News
    7.9 Ferring Pharmaceuticals, Inc.
        7.9.1 Ferring Pharmaceuticals, Inc. Corporate Summary
        7.9.2 Ferring Pharmaceuticals, Inc. Business Overview
        7.9.3 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.9.4 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.9.5 Ferring Pharmaceuticals, Inc. Key News
    7.10 Crinetics Pharmaceuticals, Inc.
        7.10.1 Crinetics Pharmaceuticals, Inc. Corporate Summary
        7.10.2 Crinetics Pharmaceuticals, Inc. Business Overview
        7.10.3 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Major Product Offerings
        7.10.4 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue in Global Market (2017-2022)
        7.10.5 Crinetics Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Polycystic Ovary Syndrome Treatment Market Opportunities & Trends in Global Market
    Table 2. Polycystic Ovary Syndrome Treatment Market Drivers in Global Market
    Table 3. Polycystic Ovary Syndrome Treatment Market Restraints in Global Market
    Table 4. Key Players of Polycystic Ovary Syndrome Treatment in Global Market
    Table 5. Top Polycystic Ovary Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Polycystic Ovary Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Polycystic Ovary Syndrome Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Polycystic Ovary Syndrome Treatment Product Type
    Table 9. List of Global Tier 1 Polycystic Ovary Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Polycystic Ovary Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Polycystic Ovary Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Polycystic Ovary Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Polycystic Ovary Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Polycystic Ovary Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Polycystic Ovary Syndrome Treatment Product Offerings
    Table 32. Sanofi Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis AG Corporate Summary
    Table 34. Novartis AG Polycystic Ovary Syndrome Treatment Product Offerings
    Table 35. Novartis AG Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Teva Pharmaceutical Industries Limited  Corporate Summary
    Table 37. Teva Pharmaceutical Industries Limited  Polycystic Ovary Syndrome Treatment Product Offerings
    Table 38. Teva Pharmaceutical Industries Limited  Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Addex Therapeutics Ltd.  Corporate Summary
    Table 40. Addex Therapeutics Ltd.  Polycystic Ovary Syndrome Treatment Product Offerings
    Table 41. Addex Therapeutics Ltd.  Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. BIOCAD Corporate Summary
    Table 43. BIOCAD Polycystic Ovary Syndrome Treatment Product Offerings
    Table 44. BIOCAD Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Merck KGaA Corporate Summary
    Table 46. Merck KGaA Polycystic Ovary Syndrome Treatment Product Offerings
    Table 47. Merck KGaA Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. AstraZeneca plc. Corporate Summary
    Table 49. AstraZeneca plc. Polycystic Ovary Syndrome Treatment Product Offerings
    Table 50. AstraZeneca plc. Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Bristol Myers Squibb Co.  Corporate Summary
    Table 52. Bristol Myers Squibb Co.  Polycystic Ovary Syndrome Treatment Product Offerings
    Table 53. Bristol Myers Squibb Co.  Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Ferring Pharmaceuticals, Inc. Corporate Summary
    Table 55. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Product Offerings
    Table 56. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Crinetics Pharmaceuticals, Inc. Corporate Summary
    Table 58. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Product Offerings
    Table 59. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Polycystic Ovary Syndrome Treatment Segment by Type in 2021
    Figure 2. Polycystic Ovary Syndrome Treatment Segment by Application in 2021
    Figure 3. Global Polycystic Ovary Syndrome Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Polycystic Ovary Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Polycystic Ovary Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Polycystic Ovary Syndrome Treatment Revenue in 2021
    Figure 8. By Type - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 12. US Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 24. China Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Polycystic Ovary Syndrome Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Polycystic Ovary Syndrome Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis AG Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Teva Pharmaceutical Industries Limited  Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Addex Therapeutics Ltd.  Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. BIOCAD Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck KGaA Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. AstraZeneca plc. Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Bristol Myers Squibb Co.  Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Polycystic Ovary Syndrome Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Polycystic Ovary Syndrome Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Polycystic Ovary Syndrome Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports